Plaque-type Psoriasis Research Trial (73 Days)

Adults aged 18-75 years old with stable, chronic plaque-type psoriasis, may qualify to participate. Individuals must have mild to moderate disease with 10% or less affected body surface area. Psoriatic plaque criteria must be met, with plaque amenable to topical treatment. Must be willing and able to avoid excess exposure to natural or artificial UV light sources, during the treatment period.

Participants will receive investigational topical gel medication (active study drug) or placebo. Investigational medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 73 days and involve about 7 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more